e-learning
resources
Barcelona 2013
Wednesday, 11.09.2013
Pulmonary circulation: clinical physiology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Central vascular pressure measurements during exercise in COPD: How to handle the respirophasic changes?
B. Boerrigter, A. Waxman, N. Westerhof, A. Vonk-Noordegraaf, D. Systrom (Amsterdam, Netherlands; Boston, United States Of America)
Source:
Annual Congress 2013 –Pulmonary circulation: clinical physiology
Session:
Pulmonary circulation: clinical physiology
Session type:
Oral Presentation
Number:
4836
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Boerrigter, A. Waxman, N. Westerhof, A. Vonk-Noordegraaf, D. Systrom (Amsterdam, Netherlands; Boston, United States Of America). Central vascular pressure measurements during exercise in COPD: How to handle the respirophasic changes?. Eur Respir J 2013; 42: Suppl. 57, 4836
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
The prevalence of ventilatory limitation at peak exercise in pulmonary arterial hypertension
Source: International Congress 2014 – Alterations of exercise and lung function in different diseases
Year: 2014
Pulmonary haemodynamics during exercise in patients with pulmonary arterial hypertension
Source: Annual Congress 2005 - Exercise testing in pulmonary arterial hypertension
Year: 2005
Pathophysiology of exercise limitation in patients with pulmonary arterial hypertension
Source: Annual Congress 2005 - Exercise testing in pulmonary arterial hypertension
Year: 2005
Daily monitoring parameters of arterial stiffness and central aortic pressure in COPD patients comorbid with arterial hypertension
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
Contrasting cardiovascular responses to exercise in mitochondrial myopathy and pulmonary arterial hypertension
Source: International Congress 2016 – Mechanisms of symptoms and exercise limitation in health and disease
Year: 2016
Comparison of exercise capacity and exercise haemodynamic relationships between severe group 3 pulmonary hypertension and pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016
Effect of pulmonary rehabilitation on cardiac function during exercise in COPD
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 1)
Year: 2013
Pulmonary vessels remodeling in COPD
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Patient perspectives on exercise training in pulmonary arterial hypertension (PAH)
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015
Cardiac function during exercise in pulmonary arterial hypertension
Source: Annual Congress 2005 - Exercise in pulmonary hypertension
Year: 2005
Central hemodynamic patterns during recovery from peak exercise
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015
Pulmonary hypertension at exercise in COPD: does it matter?
Source: Eur Respir J 2013; 41: 1002-1004
Year: 2013
Relationship between exercise desaturation and pulmonary haemodynamics in COPD patients
Source: Eur Respir J 2004; 24 : 580-586
Year: 2004
An open label study of ambrisentan in patients with exercise induced pulmonary arterial hypertension (EiPAH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013
The effect of pulmonary hypertension on aerobic exercise capacity in lung transplant candidates with advanced COPD
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014
Right ventricular response during exercise in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Clinical exercise physiology in health and disease
Year: 2015
The prevalence and characteristics of pulmonary hypertension in severe COPD
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Pulmonary vascular response patterns during exercise in interstitial lung disease (ILD)
Source: International Congress 2014 – Mechanisms of exercise limitation in disease
Year: 2014
Safety related to maximal cardiopulmonary exercise testing in patients with pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016
Pulmonary hypertension and COPD: Clinical assessment and biomarkers
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept